12-109561067-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_052845.4(MMAB):c.557G>A(p.Arg186Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000745 in 1,610,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R186W) has been classified as Pathogenic.
Frequency
Consequence
NM_052845.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMAB | NM_052845.4 | c.557G>A | p.Arg186Gln | missense_variant | 7/9 | ENST00000545712.7 | NP_443077.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMAB | ENST00000545712.7 | c.557G>A | p.Arg186Gln | missense_variant | 7/9 | 1 | NM_052845.4 | ENSP00000445920.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151946Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249300Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135182
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1458936Hom.: 0 Cov.: 35 AF XY: 0.00000689 AC XY: 5AN XY: 726002
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151946Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74194
ClinVar
Submissions by phenotype
Methylmalonic aciduria, cblB type Pathogenic:3Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | May 30, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 29, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 186 of the MMAB protein (p.Arg186Gln). This variant is present in population databases (rs773059864, gnomAD 0.0009%). This missense change has been observed in individuals with clinical features of cobalamin B type methylmalonic aciduria (PMID: 16410054, 33453710, 33552909, 34796408). ClinVar contains an entry for this variant (Variation ID: 552212). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MMAB protein function with a positive predictive value of 80%. This variant disrupts the p.Arg186 amino acid residue in MMAB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12471062, 16410054, 16439175, 19625202). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 13, 2020 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Baumgartner lab, University Children's Hospital Zurich | Jun 01, 2021 | - - |
Methylmalonic acidemia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 26, 2022 | The p.Arg186Gln variant in MMAB has been reported in the homozygous state in 3 individuals with methylmalonic acidemia (Lerner-Ellis 2006 PMID: 16410054, Kiykim 2021 PMID: 33552909). It has also been reported in ClinVar (Variation ID 552212) and it has been identified in 2/67960 of European chromosomes by gnomAD (https://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Another variant involving this codon (p.Arg186Trp) has been identified in individuals with methylmalonic acidemia and is classified as pathogenic by several clinical laboratories in ClinVar and they occur in one of highly conserved residus, which are thought to be involved in the formation of the active site where many pathogenic variants in this gene have been identified (Lerner-Ellis 2006 PMID: 16410054). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal autosomal methylmalonic acidemia. ACMG/AMP criteria provided: PM2_Supporting, PP3, PM5, PM3, PM1. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at